These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26203158)

  • 1. Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid.
    Laakso MP; Jukarainen NM; Vepsäläinen J
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1286-90. PubMed ID: 26203158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
    J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
    Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
    J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
    Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
    Spies PE; Melis RJ; Sjögren MJ; Rikkert MG; Verbeek MM
    J Alzheimers Dis; 2009; 16(2):363-9. PubMed ID: 19221426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
    Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
    J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers in spinal fluid of patients with dementia].
    Skogseth RE; Fladby T; Mulugeta E; Aarsland D
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid NrCAM is not a Suitable Biomarker to Discriminate between Dementia Disorders--A Pilot Study.
    Müller M; Claassen JA; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2015; 46(3):605-9. PubMed ID: 25812850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Word list and story recall elicit different patterns of memory deficit in patients with Alzheimer's disease, frontotemporal dementia, subcortical ischemic vascular disease, and Lewy body dementia.
    Perri R; Fadda L; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2013; 37(1):99-107. PubMed ID: 23792693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias.
    de Souza LC; Lamari F; Belliard S; Jardel C; Houillier C; De Paz R; Dubois B; Sarazin M
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):240-6. PubMed ID: 20802215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias.
    Simonsen AH; Mattila J; Hejl AM; Garde E; van Gils M; Thomsen C; Lötjönen J; Soininen H; Waldemar G
    Dement Geriatr Cogn Disord; 2014; 37(3-4):207-13. PubMed ID: 24193095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
    Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
    J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
    Brunnström H; Rawshani N; Zetterberg H; Blennow K; Minthon L; Passant U; Englund E
    Alzheimers Dement; 2010 Mar; 6(2):104-9. PubMed ID: 20298970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
    Clark CM; Xie S; Chittams J; Ewbank D; Peskind E; Galasko D; Morris JC; McKeel DW; Farlow M; Weitlauf SL; Quinn J; Kaye J; Knopman D; Arai H; Doody RS; DeCarli C; Leight S; Lee VM; Trojanowski JQ
    Arch Neurol; 2003 Dec; 60(12):1696-702. PubMed ID: 14676043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.